European regulator recommends remdesivir for Covid-19 treatment
The European healthcare regulator has recommended the conditional approval of Gilead Sciences Inc’s antiviral treatment, remdesivir, for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent.
from Hindustan Times - world https://ift.tt/3i3C1gE
via IFTTT
from Hindustan Times - world https://ift.tt/3i3C1gE
via IFTTT
Comments
Post a Comment